Digistain® works biologically downstream using a proprietary method to measure markers at the protein level to deliver a robust and personalised risk score for cancer therapy guidance
Poster presented at the American Society of Breast Cancer Surgeons 2023 Annual Meeting
Poster presented at the 2022 American Society for Cancer Research Conference
Poster presented at the American Society of Clinical Oncology 2023 Annual Meeting
Poster presented at the European Congress of Pathology
Subscribe to leading news and insights
To stay updated about Digistain’s developments, enter your details opposite. We promise only to send you important news.